Chief Financial Officer @ (July 2022 - August 2024)
Chief Financial Officer @ (October 2021 - July 2022)
Vice President Finance and Administration @ Harpoon Therapeutics (July 2018 - October 2021)
VP, Finance and Administration @ Immune Design (April 2015 - February 2018)
Corporate Controller and Senior Director of Finance @ (July 2013 - April 2015)
Corporate Controller and Director of Finance @ (May 2011 - July 2013)
Corporate Controller @ (June 2010 - June 2011)
Manager - Financial Planning and Analysis @ (May 2008 - June 2010)
Manager - Audit @ (October 2002 - May 2008)
Christopher Whitmore Education
UC Santa Barbara
BA (Business, Economics, Accounting, Sports Management)
Christopher Whitmore Skills
Sarbanes-Oxley Act
Strategic Planning
Financial Reporting
Budgets
Financial Analysis
Auditing
Finance
Sarbanes Oxley Act
Management
Financial Modeling
Due Diligence
Accounting
Mergers and Acquisitions
SEC filings
Financial Planning
Christopher Whitmore Summary
Christopher Whitmore, based in California, United States, is currently a Chief Financial Officer at Ray Therapeutics, Inc.. Christopher Whitmore brings experience from previous roles at Immune-Onc Therapeutics, Notable, Harpoon Therapeutics and Immune Design. Christopher Whitmore holds a BA in Business, Economics, Accounting, Sports Management @ UC Santa Barbara. With a robust skill set that includes Sarbanes-Oxley Act, Strategic Planning, Financial Reporting, Budgets, Financial Analysis and more. Christopher Whitmore has 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Whitmore?
Find contact details for 700 million professionals.